Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas

Agata Chłopik, M. Angelica Selim, Yan Peng, Cheng Lin Wu, Gemma Tell-Marti, Kristen M. Paral, Sara C. Shalin, Stefan Kraft, Chao Kai Hsu, Christopher R. Shea, Susana Puig, Maria Teresa Fernandez-Figueras, Wojciech Biernat, Janusz Ryś, Andrzej Marszalek, Mai P. Hoang

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The prognostic role of PDL1 expression, CD8+ and FoxP3+ lymphocytes in vulvar melanomas has not been studied. We correlated PDL1 expression and CD8+ and FoxP3+ immune infiltrates with clinicopathologic variables and patient outcomes in a series of 75 vulvar melanomas. Tumoral PDL1 expression (>5%) was seen in 23% of cases. By Fisher exact test, PDL1 expression and peritumoral FoxP3+ lymphocytes significantly correlated with less disease-specific death. By linear regression analysis, correlations between tumoral PDL1 expression with the density of tumoral CD8+ and peritumoral CD8+ lymphocytes, tumoral FoxP3+ with tumoral CD8+ lymphocytes, and peritumoral FoxP3+ with peritumoral CD8+ lymphocytes were observed. By univariate analyses, tumor thickness >4 mm predicted poorer progression-free survival, melanoma-specific survival, and overall survival. PDL1 expression >5% and peritumoral CD8+, peritumoral FoxP3+, and tumoral FoxP3+ lymphocytes correlated with better overall survival. By multivariate analyses, high peritumoral FoxP3+ lymphocytes independently predicted better melanoma-specific survival (P =.023), and tumor thickness independently predicted poorer progression-free survival (P =.05) and overall survival (P =.039). In conclusion, our study shows that, independent from tumor thickness, an increased density of peritumoral FoxP3+ lymphocytes may positively impact survival in a subset of vulvar melanomas. Tumoral PDL1 expression correlated with tumoral as well as peritumoral CD8+ and FoxP3+ lymphocytes, supportive of an adaptive immune response. Although the frequency of PDL1 expression is low in vulvar melanoma, its expression may identify a subset of vulvar melanoma that might respond to immunotherapy.

Original languageEnglish (US)
Pages (from-to)176-183
Number of pages8
JournalHuman Pathology
Volume73
DOIs
StatePublished - Mar 1 2018

Keywords

  • CD8
  • FoxP3
  • Immunohistochemistry
  • PDL1
  • Survival
  • Vulvar melanoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas'. Together they form a unique fingerprint.

  • Cite this

    Chłopik, A., Selim, M. A., Peng, Y., Wu, C. L., Tell-Marti, G., Paral, K. M., Shalin, S. C., Kraft, S., Hsu, C. K., Shea, C. R., Puig, S., Fernandez-Figueras, M. T., Biernat, W., Ryś, J., Marszalek, A., & Hoang, M. P. (2018). Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. Human Pathology, 73, 176-183. https://doi.org/10.1016/j.humpath.2017.12.022